• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫唑嘌呤用于青少年慢性关节炎患者:一项长期随访研究。

Azathioprine in patients with juvenile chronic arthritis: a longterm followup study.

作者信息

Savolainen H A, Kautiainen H, Isomäki H, Aho K, Verronen P

机构信息

Rheumatism Foundation Hospital, Heinola, Finland.

出版信息

J Rheumatol. 1997 Dec;24(12):2444-50.

PMID:9415656
Abstract

OBJECTIVE

To evaluate drug survival, efficacy, side effects, and longterm toxicity of azathioprine treatment in patients with juvenile chronic arthritis (JCA).

METHODS

In an uncontrolled, prospective study we evaluated 129 consecutive patients with JCA refractory to therapy in whom azathioprine treatment was begun during 1980-1989. In the first 29 patients, a 2 year trial was planned, while for the remaining 100 patients the protocol was to continue until remission or dropout. The median treatment period was 13 months (range 3 days-8.5 yrs). Patients were assessed every 2 months for 2 years for efficacy, side effects, growth and need for glucocorticoids, and outcome evaluated in late 1996.

RESULTS

Remission without drugs was attained in 19 patients (15%); in addition, temporary remission in patients continuing treatment was attained in 18 cases (14%). Treatment was discontinued due to side effects in 18 cases (14%); in two-thirds of these cases side effects occurred during the first 2 months. Of the total number of patients, 49 (38%) completed 2 years of treatment, with significant improvement in both clinical and laboratory indices of disease activity. Treatment had no noticeable effect on iridocyclitis. One patient died of cytomegalovirus infection during azathioprine treatment.

CONCLUSION

Azathioprine is a useful drug in severe JCA, with a sustained effect and acceptable side effects. Even in cases of incomplete remission, its glucocorticoid sparing effect was noteworthy.

摘要

目的

评估硫唑嘌呤治疗青少年慢性关节炎(JCA)患者的药物留存率、疗效、副作用及长期毒性。

方法

在一项非对照前瞻性研究中,我们评估了1980年至1989年间开始使用硫唑嘌呤治疗的129例连续的JCA难治性患者。前29例患者计划进行为期2年的试验,而其余100例患者的方案是持续治疗直至缓解或退出。中位治疗期为13个月(范围3天至8.5年)。每2个月对患者进行一次评估,持续2年,评估疗效、副作用、生长情况及对糖皮质激素的需求,并于1996年末评估结局。

结果

19例患者(15%)实现了无药缓解;此外,继续治疗的患者中有18例(14%)实现了暂时缓解。18例患者(14%)因副作用而停药;其中三分之二的病例在最初2个月内出现副作用。在所有患者中,49例(38%)完成了2年治疗,疾病活动的临床和实验室指标均有显著改善。治疗对虹膜睫状体炎无明显效果。1例患者在硫唑嘌呤治疗期间死于巨细胞病毒感染。

结论

硫唑嘌呤是治疗重度JCA的有效药物,具有持续疗效且副作用可接受。即使在不完全缓解的病例中,其糖皮质激素节省作用也值得注意。

相似文献

1
Azathioprine in patients with juvenile chronic arthritis: a longterm followup study.硫唑嘌呤用于青少年慢性关节炎患者:一项长期随访研究。
J Rheumatol. 1997 Dec;24(12):2444-50.
2
Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis.苯丁酸氮芥治疗严重青少年慢性关节炎:长期随访及对淀粉样变性的特别关注
J Rheumatol. 1999 Apr;26(4):898-903.
3
Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup.青少年慢性关节炎的缓解:一项对683例连续病例进行的队列研究,平均随访10年。
J Rheumatol. 2003 Mar;30(3):579-84.
4
Antirheumatic effects of first-line agents in the treatment of juvenile chronic arthritis.一线药物治疗幼年慢性关节炎的抗风湿作用。
Rev Med Chir Soc Med Nat Iasi. 1997 Jul-Dec;101(3-4):134-8.
5
Combination drug therapy of seropositive rheumatoid arthritis.
J Rheumatol. 1995 Sep;22(9):1636-45.
6
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.重复静脉输注抗肿瘤坏死因子α单克隆抗体英夫利昔单抗治疗持续活动、难治性幼年特发性关节炎的疗效:一项开放标签前瞻性研究的结果
Arthritis Rheum. 2005 Feb;52(2):548-53. doi: 10.1002/art.20793.
7
A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.一项关于硫唑嘌呤单药治疗与硫唑嘌呤联合奥沙拉嗪用于维持激素依赖型溃疡性结肠炎缓解的前瞻性随机观察者盲法2年试验。
Am J Gastroenterol. 2004 Jun;99(6):1122-8. doi: 10.1111/j.1572-0241.2004.11481.x.
8
Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.依那西普在难治性附着点炎相关关节炎中的长期疗效。
J Rheumatol. 2004 Oct;31(10):2055-61.
9
Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.青少年特发性关节炎相关淀粉样变性的长期预后。
J Rheumatol. 2008 May;35(5):907-12. Epub 2008 Mar 15.
10
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.依那西普治疗青少年特发性关节炎有效性和安全性的长期随访:荷兰国家登记研究
Ann Rheum Dis. 2009 May;68(5):635-41. doi: 10.1136/ard.2007.087411. Epub 2008 Apr 15.

引用本文的文献

1
[Current therapy of polyarticular forms of juvenile idiopathic arthritis].[青少年特发性关节炎多关节型的当前治疗方法]
Z Rheumatol. 2016 Apr;75(3):284-91. doi: 10.1007/s00393-016-0063-9.
2
Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches.多关节型幼年特发性关节炎——流行病学与管理方法
Clin Epidemiol. 2014 Oct 24;6:379-93. doi: 10.2147/CLEP.S53168. eCollection 2014.
3
Update on the treatment of juvenile idiopathic arthritis.幼年特发性关节炎的治疗进展。
Curr Allergy Asthma Rep. 2013 Aug;13(4):337-46. doi: 10.1007/s11882-013-0351-2.
4
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.针对与幼年特发性关节炎相关的葡萄膜炎的抗炎治疗的循证、跨学科指南。
Rheumatol Int. 2012 May;32(5):1121-33. doi: 10.1007/s00296-011-2126-1. Epub 2011 Nov 15.
5
Cytomegalovirus infection in pediatric rheumatic diseases: a review.儿童风湿性疾病中的巨细胞病毒感染:综述。
Pediatr Rheumatol Online J. 2010 May 20;8:17. doi: 10.1186/1546-0096-8-17.
6
[The treatment of juvenile rheumatism: pharmacotherapy].[青少年风湿病的治疗:药物疗法]
Z Rheumatol. 2005 Jun;64(5):308-16. doi: 10.1007/s00393-005-0750-4.
7
[Uveitis in conjunction with rheumatological diseases in childhood].[儿童葡萄膜炎合并风湿性疾病]
Ophthalmologe. 2005 May;102(5):463-76. doi: 10.1007/s00347-005-1182-x.
8
The use of immunosuppressive and cytotoxic drugs in non-malignant disease.免疫抑制和细胞毒性药物在非恶性疾病中的应用。
Arch Dis Child. 2000 Sep;83(3):259-64. doi: 10.1136/adc.83.3.259.
9
Medical management of children with juvenile rheumatoid arthritis.青少年类风湿关节炎患儿的医学管理
Drugs. 1999 Nov;58(5):831-50. doi: 10.2165/00003495-199958050-00006.